Prime Medicine, Inc. ( PRME) - Key Metrics
PRME Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.31 | -$0.25 | -$0.25 |
| 2025Q3 | $0.01 | -$0.32 | -$0.22 | -$0.22 |
| 2025Q2 | $0.01 | -$0.41 | -$0.32 | -$0.33 |
| 2025Q1 | $0.01 | -$0.40 | -$0.37 | -$0.39 |
PRME Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.80 |
| 2025Q3 | ? | -4.39 |
| 2025Q2 | ? | -1.52 |
| 2025Q1 | ? | -1.25 |
PRME
Price: $2.87
52 week price:
Earnings Per Share: -1.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 542.8 million